从供方激励角度制订药品政策的探讨  

Exploration of Pharmaceutical Policy Formulation from the Perspective of Provider Incentive

作　　者：侯建林[1] 成刚[1] 

机构地区：[1]北京大学中国卫生发展研究中心,北京100191

出　　处：《中国药房》2012年第16期1441-1444,共4页China Pharmacy

基　　金：China Medical Board资助项目;美国中华医学基金会(CMB09991)

摘　　要：目的:为完善我国药品政策制订方法提供参考。方法:采用文献评阅方法总结药品消费与供给的特点,回顾我国近期主要药品政策及其影响,并介绍相关国际经验,探讨从供方激励角度制订药品政策的必要性、重要性与相关做法。结果与结论:我国在药品政策制订中,应重视医疗卫生机构、医师、医药企业等供方因素对药品消费的重要影响,调整过度依赖约束与控制的做法,建立针对供方的经济激励机制,使其在促进合理用药、控制药品费用等方面的努力中受益而不是受损,以提高政策的实施效果。OBJECTIVE：To provide reference for the improvement of pharmaceutical policy formulation method.METHODS：On the basis of literature review,the article briefly summarized the characteristics of pharmaceutical consumption and supply,reviewed major pharmaceutical policies and their effects in China,and introduced relevant international experiences.The necessity,importance and relevant methods of pharmaceutical policy formulation were also investigated from the perspective of provider incentive.RESULTS CONCLUSIONS：In respect of pharmaceutical policy formulation,we should attach importance to the effects of providers,i.g.medical institution,physicians,pharmaceutical enterprises,on pharmaceutical consumption,avoid over-reliance,over-restriction and control of their behaviors,and establish economic incentive mechanism for providers to ensure that they benefit rather than suffer from efforts in promoting rational drug use and controlling pharmaceutical expenses in order that better policy effects can be achieved.

关 键 词：供给方 激励 药品政策 

分 类 号：R95[医药卫生—药学]